Literature DB >> 8603947

Pneumocystis carinii infection in transgenic B cell-deficient mice.

H Marcotte1, D Levesque, K Delanay, A Bourgeault, R de la Durantaye, S Brochu, M C Lavoie.   

Abstract

Pneumocystis carinii is an important cause of pneumonia in immunocompromised hosts. Both cellular and humoral immunity seem important in resistance to this pathogen, but the specific role of each component is poorly understood. An outbreak of P. carinii pneumonia in transgenic B cell-deficient mice (muMT) was studied. Over 4 months, >50% of 41 muMT/muMT mice maintained in a sterile environment died of pneumonia. Some mice had concurrent infection with Pasteurella pneumotropica. Homozygous muMT/muMT mice had no detectable serum immunoglobulins, while their heterozygous muMT/+ counterparts had normal levels of IgM, IgG, and IgA and did not develop pneumonia. The infection was controlled by treating the mice with trimethoprim-sulfamethoxazole, and the pathogen was eliminated by cesarean rederivation. These observations suggest an important role for B cells in the host defense against P. carinii.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8603947     DOI: 10.1093/infdis/173.4.1034

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  37 in total

Review 1.  Immunological features of Pneumocystis carinii infection in humans.

Authors:  P D Walzer
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

2.  Alveolar macrophages in neonatal mice are inherently unresponsive to Pneumocystis murina infection.

Authors:  Cathryn Kurkjian; Melissa Hollifield; J Louise Lines; Amy Rogosky; Kerry M Empey; Mahboob Qureshi; Stephen A Brown; Beth A Garvy
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

Review 3.  Complications of long-term therapy for ANCA-associated systemic vasculitis.

Authors:  Nadezhda Wall; Lorraine Harper
Journal:  Nat Rev Nephrol       Date:  2012-06-05       Impact factor: 28.314

4.  CD8 T cells modulate CD4 T-cell and eosinophil-mediated pulmonary pathology in pneumocystis pneumonia in B-cell-deficient mice.

Authors:  Steve D Swain; Nicole N Meissner; Allen G Harmsen
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

5.  Complement and Fc function are required for optimal antibody prophylaxis against Pneumocystis carinii pneumonia.

Authors:  Jesse Wells; Constantine G Haidaris; Terry W Wright; Francis Gigliotti
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

6.  STAT4-dependent and -independent Th2 responses correlate with protective immunity against lung infection with Pneumocystis murina.

Authors:  Riley C Myers; Chad W Dunaway; Michael P Nelson; Jennifer L Trevor; Alison Morris; Chad Steele
Journal:  J Immunol       Date:  2013-05-06       Impact factor: 5.422

7.  Pneumocystis jirovecii pneumonia in two patients with systemic lupus erythematosus after rituximab therapy.

Authors:  F Bonilla-Abadía; J F Betancurt; J C Pineda; J D Vélez; G J Tobón; C A Cañas
Journal:  Clin Rheumatol       Date:  2014-01-09       Impact factor: 2.980

8.  No apparent influence of immunoglobulins on indigenous oral and intestinal microbiota of mice.

Authors:  H Marcotte; M C Lavoie
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

Review 9.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

10.  The life cycle stages of Pneumocystis murina have opposing effects on the immune response to this opportunistic, fungal pathogen.

Authors:  Heather M Evans; Grady L Bryant; Beth A Garvy
Journal:  Infect Immun       Date:  2016-08-29       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.